Zhonghong Wei

Nanjing University of Chinese Medicine

H指数:19

被引数:1,318

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Pharmacological inhibition of Alistipes putredinis-derived indole-3-acetic acid by baicalin suppresses stress-driven breast cancer metastasis

黄芩素通过药理学抑制产气肠杆菌来源的吲哚-3-乙酸抑制应激驱动的乳腺癌转移

Microbiome

IF12.7

2026-09-040

Discovery of natural product-derived rosavin as a programmed death-ligand 1 inhibitor for cancer immunotherapy

天然产物衍生物rosavin作为癌症免疫疗法中程序性死亡配体1抑制剂的发现

Phytomedicine

IF8.3

2026-07-010

PRE

Restoring Gut Microbiota Homeostasis to Ameliorate Colitis via Huangqin Decoction

Phytomedicine

IF8.3

2026-02-060

PRE

Synergistic effects of ferulic acid and wogonin on cholestatic liver injury via gut microbiota modulation

阿魏酸和汉黄芩素通过肠道菌群调控对胆汁淤积性肝损伤的协同效应

npj Biofilms and Microbiomes

IF9.2

2025-12-180

OAAI

Synergistic targeting of ITGA5/CCN1 by Sparganii Rhizoma and Curcumae Rhizoma suppresses breast cancer metastasis via angiogenesis and adhesion

莪术和郁金协同靶向ITGA5/CCN1抑制乳腺癌转移，其机制涉及血管生成和粘附。

Phytomedicine

IF8.3

2025-10-190

PRE

Microbiota-derived urocanic acid triggered by tyrosine kinase inhibitors potentiates cancer immunotherapy efficacy

微生物群衍生的尿刊酸由酪氨酸激酶抑制剂触发，增强了癌症免疫治疗的疗效

Cell Host & Microbe

IF18.7

2025-05-280

PRE

Ginseng polysaccharides ameliorate colorectal tumorigenesis through Lachnospiraceae-mediated immune modulation

人参多糖通过Lachnospiraceae介导的免疫调节改善结直肠肿瘤发生

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES

IF8.5

2025-05-010

PRE

Promises of natural products as clinical applications for cancer

天然产物作为癌症临床应用的潜力

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER

IF8.3

2025-02-011

PRE

Synergistic potentiation of the anti-metastatic effect of a Ginseng-Salvia miltiorrhiza herbal pair and its biological ingredients via the suppression of CD62E-dependent neutrophil infiltration and NETformation

人参-丹参配伍中药对CD62E依赖性中性粒细胞浸润和NET形成的抑制，协同增强其抗转移效应及其生物活性成分。

Journal of Advanced Research

IF13

2024-10-300

OAAI

Recent advances in identifying protein targets of bioactive natural products

HELIYON

IF3.6

2024-07-011

OAAI

Systematic optimization and evaluation of culture conditions for the construction of circulating tumor cell clusters using breast cancer cell lines

BMC CANCER

IF3.4

2024-04-230

OAAI

Unveiling the covert interaction between gut microbiota and neutrophils to drive colorectal cancer metastasis

揭示肠道微生物群和中性粒细胞之间的秘密相互作用以驱动结直肠癌转移

EUROPEAN JOURNAL OF PHARMACOLOGY

IF4.7

2024-01-015

PRE

Clostridium butyricum and Clostridium tyrobutyricum: angel or devil for necrotizing enterocolitis?

酪酸梭菌和酪酸梭菌: 坏死性小肠结肠炎的天使还是魔鬼？

MSYSTEMS

IF4.6

2023-12-212

OAAI

Rosmarinic acid in combination with ginsenoside Rg1 suppresses colon cancer metastasis via co-inhition of COX-2 and PD1/PD-L1 signaling axis

ACTA PHARMACOLOGICA SINICA

IF8.4

2023-09-258

PRE

Capsaicin shapes gut microbiota and pre-metastatic niche to facilitate cancer metastasis to liver

PHARMACOLOGICAL RESEARCH

IF10.5

2023-02-0123

OAAI

Ginseng polysaccharides: Potential antitumor agents

JOURNAL OF GINSENG RESEARCH

IF5.6

2023-01-0115

OAAI

Systemic pharmacological verification of Salvia miltiorrhiza-Ginseng Chinese herb pair in inhibiting spontaneous breast cancer metastasis

BIOMEDICINE & PHARMACOTHERAPY

IF7.5

2022-12-016

OAAI

Crosstalk between traditional Chinese medicine-derived polysaccharides and the gut microbiota: A new perspective to understand traditional Chinese medicine

PHYTOTHERAPY RESEARCH

IF6.3

2022-09-1320

PRE

Pharmacological manipulation of Ezh2 with salvianolic acid B results in tumor vascular normalization and synergizes with cisplatin and T cell-mediated immunotherapy

PHARMACOLOGICAL RESEARCH

IF10.5

2022-08-0130

PRE

Novel GSK-3 kinase inhibitor Pym-5 induces GSK-3β rather than GSK-3α-dependent melanogenesis in murine melanoma cells

新型GSK-3激酶抑制剂Pym-5在鼠黑色素瘤细胞中诱导GSK-3β 而不是gsk-3α 依赖性黑素生成

JOURNAL OF DERMATOLOGICAL SCIENCE

IF4

2022-06-012

PRE

Zhonghong Wei

个人简介

教育背景

工作经历

荣誉奖项

研究方向